Dual-Action Psoriasis Therapy Using Microneedles
Author Information
Author(s): Wang Zi Yi, Zhao Ze Qiang, Sheng Yu Jun, Chen Ke Jun, Chen Bo Zhi, Guo Xin Dong, Cui Yong
Primary Institution: Beijing University of Chemical Technology
Hypothesis
Can a self-locking microneedle patch effectively deliver a TYK2 inhibitor and a vitamin D derivative to treat psoriasis?
Conclusion
The dual-action microneedle therapy effectively reduces both local and systemic inflammation in psoriasis.
Supporting Evidence
- The microneedle patch effectively downregulated psoriasis-associated IL-23/IL-17 pathways.
- Mice treated with the patch showed significant alleviation in erythema and skin thickness.
- The patch demonstrated excellent biosafety with no significant weight loss in mice.
Takeaway
This study created a special patch that helps treat psoriasis by delivering medicine directly to the skin, making it work better and with fewer side effects.
Methodology
The study developed a microneedle patch that delivers a TYK2 inhibitor and a vitamin D derivative, tested in a mouse model of psoriasis.
Limitations
The study was conducted in a mouse model, which may not fully replicate human psoriasis.
Participant Demographics
Female BALB/c mice, 6–8 weeks old.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website